Managing Raynaud's: Lifestyle and Medications
At a Glance
Raynaud's management starts with keeping the whole body warm, avoiding cold triggers and nicotine, and reducing vibration exposure. Calcium channel blockers are usually first-line when lifestyle measures are not enough; PDE5 inhibitors may help, but they must never be combined with nitrates.
Managing Raynaud phenomenon is a step-by-step process that begins with protecting your body from the cold and, if necessary, moves into medications that help your blood vessels stay open. For many people with primary Raynaud’s, lifestyle adjustments alone are enough to manage symptoms [1]. For those with secondary Raynaud’s, medications are often needed to maintain consistent blood flow and prevent tissue damage [2].
First Aid: During an Attack
When an attack happens, follow a step-by-step plan:
- Move to Warmth: Get out of the cold environment immediately if possible.
- Warm Gradually: Put on a coat to warm your entire body, not just your hands. Run warm (not hot) water over your hands or tuck them into your armpits.
- Remove Restrictions: Take off tight rings, watches, or restrictive clothing.
- Avoid Direct High Heat: Do not use direct high heat or heating pads on numb skin. Because your sensation is reduced, you can easily suffer severe burns.
- If a finger remains intensely painful, persistently pale or blue, and does not resolve with warmth, seek prompt medical assessment.
Foundational Lifestyle Measures
The first line of defense is always non-pharmacological—actions you take to prevent the “overreaction” of your blood vessels before it starts.
- Core Warmth: It is not enough to just wear gloves. When your core temperature drops, your body’s natural reflex is to pull blood away from your fingers and toes to protect your internal organs [3]. Keeping your torso warm with layers or a vest can help prevent this reflex [4].
- Trigger Avoidance: Identifying personal triggers is key. This might mean using an insulated sleeve for cold drinks, wearing gloves to handle frozen food, or pre-heating your car in the winter [5].
- Smoking Cessation: Nicotine is a powerful vasoconstrictor, meaning it directly tells your blood vessels to narrow. Quitting smoking is one of the most impactful ways to improve your circulation [6][7].
- Workplace Adjustments: If your job involves vibrating tools (like drills or grinders), reducing exposure is vital to prevent further damage to the vessel linings [8][9].
First-Line Medications: Calcium Channel Blockers
When lifestyle changes aren’t enough, doctors usually prescribe dihydropyridine calcium channel blockers (CCBs), such as nifedipine or amlodipine [2]. These drugs work by relaxing the smooth muscles in the walls of your blood vessels, allowing them to stay open even in the cold [10].
- Efficacy: CCBs are the most studied treatment for Raynaud’s. On average, they can modestly reduce the frequency of attacks by about 3 to 6 per week [10]. They tend to be slightly more effective in primary Raynaud’s than in secondary cases, but they remain the standard first choice for both [10][2].
- Side Effects: Because these medications dilate blood vessels throughout the body, they can cause systemic symptoms. Common “dose-limiting” side effects (meaning the dose cannot be raised further) include:
Second-Line Medications: PDE5 Inhibitors
If CCBs are not effective or the side effects are too strong, doctors may turn to phosphodiesterase-5 (PDE5) inhibitors, such as sildenafil or tadalafil [2].
- Role in Secondary Raynaud’s: These medications are particularly important for patients with connective tissue diseases (CTDs) like systemic sclerosis [11]. They have been shown to reduce the severity and duration of attacks and can even help heal painful fingertip ulcers [12][13].
- How They Work: They increase the levels of a chemical that helps blood vessels relax and widen. They are often used as an “add-on” to CCBs or as a replacement [2][14].
Targeted Treatments: Topical Nitrates
For some patients, a topical nitrate (like nitroglycerin ointment or patches) may be helpful [15]. These are applied directly to the skin of the hands or feet.
- Limited Use: While they can improve blood flow in the area where they are applied, the evidence for preventing daily attacks is less certain than for oral medications [16][17].
- Side Effects: Even though they are applied to the skin, some of the medication enters the bloodstream and can cause significant headaches or dizziness in some people [15][17].
⚠️ FATAL MEDICATION INTERACTION WARNING ⚠️
You must NEVER combine a PDE5 inhibitor (such as sildenafil or tadalafil) with ANY form of nitrate (including topical nitroglycerin ointment, patches, or oral nitrates).
Taking these medications together can cause a sudden, dangerously low drop in blood pressure that can be fatal.
- This applies even if the medications were prescribed by different doctors for different reasons.
- Other medications, such as riociguat, are also strictly contraindicated.
- Always provide your prescriber and pharmacist with a complete list of your medications, over-the-counter drugs, and supplements before starting any new therapy.
Clinician-Directed Dose Adjustments
Your healthcare provider will work with you to find the lowest effective dose that manages your symptoms while minimizing side effects. While it is common for a clinician to suggest taking higher doses in the winter and reducing them during the summer months, do not change your dose without prescriber direction. Any seasonal change must be supervised by your clinician, taking into account your blood pressure, side effects, and overall health.
Common questions in this guide
What should I do if a Raynaud attack does not go away?
Can lifestyle changes control Raynaud's symptoms?
What medicines are usually used for Raynaud's?
Can I take sildenafil or tadalafil with nitroglycerin?
What side effects should I watch for with Raynaud medications?
Should I change my Raynaud medication dose in winter?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Medication options
Could a calcium channel blocker like nifedipine or amlodipine be an option for my Raynaud's?
Side effects
What side effects might a calcium channel blocker cause, and how would they be weighed against benefits?
Medication safety
Should I give my pharmacist a complete list of my medicines, over-the-counter drugs, and supplements?
Get notified when new evidence is published on Raynaud disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
The role of the dermatologist in Raynaud's phenomenon: a clinical challenge.
Matucci-Cerinic C, Nagaraja V, Prignano F, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(7)):1120-1127 doi:10.1111/jdv.14914.
PMID: 29512213 - 2
Recent advances in the workup and management of Raynaud phenomenon.
Lis-Święty A
Polish archives of internal medicine 2019; (129(11)):798-808 doi:10.20452/pamw.15008.
PMID: 31577265 - 3
Raynaud's Phenomenon: A Vascular Acrosyndrome That Requires Long-Term Care.
Klein-Weigel P, Sander O, Reinhold S, et al.
Deutsches Arzteblatt international 2021; (118(Forthcoming)).
PMID: 33632387 - 4
Arm heating to relieve Raynaud's phenomenon in systemic sclerosis: A single-arm multicentre prospective clinical trial.
Watanabe A, Shima Y, Takahashi H, et al.
Modern rheumatology 2023; (33(5)):968-974 doi:10.1093/mr/roac116.
PMID: 36124934 - 5
Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
Linnemann B, Erbe M
VASA. Zeitschrift fur Gefasskrankheiten 2016; (45(3)):201-12 doi:10.1024/0301-1526/a000526.
PMID: 27129065 - 6
The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
Silva C, Solanki KK, White DHN
Rheumatology and immunology research 2022; (3(2)):84-89 doi:10.2478/rir-2022-0014.
PMID: 36465326 - 7
Raynaud's Syndrome: a neglected disease.
Poredos P, Poredos P
International angiology : a journal of the International Union of Angiology 2016; (35(2)):117-21.
PMID: 25673314 - 8
Hand-arm vibration and the risk of vascular and neurological diseases-A systematic review and meta-analysis.
Nilsson T, Wahlström J, Burström L
PloS one 2017; (12(7)):e0180795 doi:10.1371/journal.pone.0180795.
PMID: 28704466 - 9
Raynaud's phenomenon in the occupational context.
Cordeiro RA, Andrade RM
Revista da Associacao Medica Brasileira (1992) 2019; (65(10)):1314-1320 doi:10.1590/1806-9282.65.10.1314.
PMID: 31721965 - 10
Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Rirash F, Tingey PC, Harding SE, et al.
The Cochrane database of systematic reviews 2017; (12()):CD000467 doi:10.1002/14651858.CD000467.pub2.
PMID: 29237099 - 11
Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials.
Khouri C, Lepelley M, Bailly S, et al.
The Lancet. Rheumatology 2019; (1(4)):e237-e246 doi:10.1016/S2665-9913(19)30079-7.
PMID: 38229380 - 12
Systematic literature review to inform the Portuguese recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases.
Costa E, Cunha-Santos F, Dourado E, et al.
ARP rheumatology 2024; (3(Apr-Jun)):128-144.
PMID: 38306796 - 13
Raynaud's phenomenon.
Hughes M, Herrick AL
Best practice & research. Clinical rheumatology 2016; (30(1)):112-32.
PMID: 27421220 - 14
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient.
Bruni C, Bellando-Randone S, Gargani L, et al.
Reumatismo 2016; (68(2)):109-11 doi:10.4081/reumatismo.2016.889.
PMID: 27608801 - 15
Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review.
Qiu O, Chan T, Luen M, et al.
Rheumatology international 2018; (38(12)):2209-2216 doi:10.1007/s00296-018-4119-9.
PMID: 30155665 - 16
Vasodilators for primary Raynaud's phenomenon.
Su KY, Sharma M, Kim HJ, et al.
The Cochrane database of systematic reviews 2021; (5()):CD006687 doi:10.1002/14651858.CD006687.pub4.
PMID: 33998674 - 17
A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon.
Curtiss P, Schwager Z, Cobos G, et al.
Journal of the American Academy of Dermatology 2018; (78(6)):1110-1118.e3 doi:10.1016/j.jaad.2018.01.043.
PMID: 29408338
This page describes lifestyle measures and medicines used to manage Raynaud phenomenon for informational purposes only and does not constitute medical advice. Ask your prescriber or pharmacist before changing treatment or combining medicines.